中医药导报2023，Vol.29Issue(11)：118-122,131,6.DOI:10.13862/j.cn43-1446/r.2023.11.022
中药治疗缺血性脑卒中质量标志物研究进展
Research Progress on Quality Markers of Ischemic Stroke Treated with Traditional Chinese Medicine
摘要
Abstract
Stroke is a large public health problem with high mortality,disability and morbidity.Ischemic stroke is one of the most common types of disease.Traditional Chinese medicine has obvious advantages in the treatment of stroke,and has less side effects.However,the key to the efficacy of traditional Chinese medicine lies in the quality markers of traditional Chinese medicines.Therefore,the comprehensive tracking and evaluation of traditional Chinese medicines for the treatment of stroke is not comprehensive enough by relying on individual index components,and it needs to be based on the quality markers of traditional Chinese medicines.In this paper,under the guidance of quality markers(Q-Marker)by consulting relevant literature,based on the delivery of chemical components of traditional Chinese medicine in the treatment of stroke,phytogenetics,pharmacokinetics,metabolomics,intestinal flora and network pharmacology etc.to comprehensively analyze and predict the quality connotation of traditional Chinese medicine for the treatment of stroke,and speculate on its effective quality markers,in order to provide a scientific basis for such research.关键词
缺血性脑卒中/中药/质量标志物/研究进展Key words
ischemic stroke/traditional Chinese medicine/quality markers/research progress分类
医药卫生引用本文复制引用
孙进峰,朱海青,张立超..中药治疗缺血性脑卒中质量标志物研究进展[J].中医药导报,2023,29(11):118-122,131,6.基金项目
上海市青松传承项目(SZY-CC2021-QSCC) （SZY-CC2021-QSCC）
上海市卫健委三年行动计划[ZY(2021-2023)-0203-04] （2021-2023）
